[1]Choukroun J, Adda F, Schoeffler C, et al. Une opportunité enparo-implantologie:le PRF. Implantodontie, 2001, 42:55-62.
[2]Dohan DM, Choukroun J, Diss A, et al.Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part Ⅰ: technological concepts and evolution.Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2006, 101(3):e37-e44.
[3]Dohan Ehrenfest DM, Del Corso M, Diss A, et al. Three-dimensional architecture and cell composition of a Choukroun’s platelet-rich fibrin clot and membrane. J Periodontol, 2010, 81(4):546-555.
[4]Dohan DM, Choukroun J, Diss A, et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part Ⅱ: platelet-related biologic features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2006, 101(3):e45-e50.
[5]Lundquist R, Dziegiel MH, Agren MS. Bioactivity and stability of endogenous fibrogenic factors in platelet-rich fibrin. Wound Repair Regen, 2008, 16(3):356-363.
[7]Dohan DM, Choukroun J, Diss A, et al. Platelet-rich fibrin(PRF) : a second-generation platelet concentrate. Part Ⅲ: leucocyte activation: a new feature for platelet concentrates? Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2006, 101(3):e51-e55.
[9]Tonelli P, Mannelli D, Brancato L, et al. Counting of platelet derived growth factor and transforming growth factor-beta in platelet-rich-plasma used in jaw bone regeneration. Minerva Stomatol, 2005, 54(1-2):23-34.
[10]Assoian RK, Grotendorst GR, Miller DM, et al. Cellular transformation by coordinated action of three peptide growth factors from human platelets. Nature, 1984, 309(5971):804-806.
[11]Anitua E, Sánchez M, Orive G, et al. The potential impact of the preparation rich in growth factors (PRGF) in different medical fields. Biomaterials, 2007, 28(31):4551-4560.
[12]Gao YG, Wang WC, Sun Y, et al. Distribution of amelotin in mouse tooth development.Anat Rec(Hoboken), 2010, 293(1):135-140.
[13]Lacoste E, Martineau L, Gagnon G. Platelet concentrates: effects of calcium and thrombin on endothelial cell proliferation and growth factor release. J Periodontol, 2003, 74(10):1498-507.
[14]Marx RE, Carlson ER, Eichstaedt RM, et al. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 1998, 85(6):638-646.
[15]Dohan Ehrenfest DM, de Peppo GM, Doglioli P, et al. Slow release of growth factors and thrombospondin-1 in Choukroun’s platelet-rich fibrin (PRF): a gold standard to achieve for all surgical platelet concentrates technologies. Growth Factors, 2009, 27(1):63-69.
[16]Tsai CH, Shen SY, Zhao JH, et al. Platelet-rich fibrin modulates cell proliferation of human periodontally related cells in vitro. J Dent Sci, 2009, 4(3):130-135.
[18]Dohan Ehrenfest DM, Doglioli P, de Peppo GM, et al.Choukroun's platelet-rich fibrin (PRF) stimulates in vitro proliferation and differentiation of human oral bone mesenchymal stem cell in a dose-dependent way. Arch Oral Biol, 2010, 55(3):185-194.
[19]Lee JW, Kim SG, Kim JY, et al. Restoration of a peri-implant defect by platelet-rich fibrin. Oral Surg Oral Med Oral Pathol Oral Radiol, 2012, 113(4):459-463.
[20]Kim BJ, Kwon TK, Baek HS, et al. A comparative study of the effectiveness of sinus bone grafting with recombinant human bone morphogenetic protein 2-coated tricalcium phosphate and platelet-rich fibrin–mixed tricalcium phosphate in Rabbits. Oral Surg Oral Med Oral Pathol Oral Radiol, 2012, 113(5):583-592.
[21]Lee EH, Kim JY, Kweon HY, et al. A combination graft of low-molecular-weight silk fibroin with Choukroun platelet-rich fibrin for rabbit calvarial defect. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2010, 109(5):e33-e38.
[22]Toffler M, Toscano N, Holtzclaw D. Osteotome-mediated sinus floor elevation using only platelet-rich fibrin: an early report on 110 patients. Implant Dent, 2010, 19(5):447-456.
[23]Simonpieri A, Choukroun J, Del Corso M, et al. Simultaneous sinus-lift and implantation using microthreaded implants and leukocyte- and platelet-rich fibrin as sole grafting material: a six-year experience. Implant Dent, 2011, 20(1):2-12.
[24]Choukroun J, Diss A, Simonpieri A, et al. Platelet-rich fibrin(PRF): a second-generation platelet concentrate. Part Ⅴ: histologic evaluations of PRF effects on bone allograft maturation in sinus lift. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2006, 101(3):299-303.
[25]Zhang Y, Tangl SF, Huber CD, et al. Effects of Choukroun’s platelet-rich fibrin on bone regeneration in combination with deproteinized bovine bone mineral in maxillary sinus augmentation: a histological and histomorphometric study. J Craniomaxillofac Surg, 2012, 40(4):321-328.
[26]Chang YC, Zhao JH. Effects of platelet-rich fibrin on human periodontal ligament fibroblasts and application for Periodontal infrabony defects. Aust Dent J, 2011, 56(4): 365-371.
[27]Thorat MK, Pradeep AR, Pallavi B. Clinical effect of autologous platelet-rich fibrin in the treatment of intra-bony defects: a controlled clinical trial. J Clin Periodontol, 2011, 38(10): 925-932.
[28]Sharma A, Pradeep AR. Treatment of 3-wall intrabony defects in patients with chronic periodontitis with autologous platelet-rich fibrin: a randomized controlled clinical trial. J Periodontol, 2011, 82(12):1705-1712.
[30]Lekovic V, Milinkovic I, Aleksic Z, et al. Platelet-rich fibrin and bovine porous bone mineral vs. platelet-rich fibrin in the treatment of intrabony periodontal defects. J Periodont Res, 2012, 47(4):409-417.
[32]Kang YH, Jeon SH, Park JY, et al. Platelet-rich fibrin is a bio-scaffold and reservoir of growth factors for tissue regeneration. Tissue Eng Part A, 2011, 17(3-4): 349-359.